Study Of Advanced Gastrointestinal Malignancies And Other Solid Tumors
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
Dose escalation of oxaliplatin, gemcitabine and capecitabine in the treatment of patients
with advanced gastrointestinal malignancies and other solid tumors.